GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Beneish M-Score

Olympus (TSE:7733) Beneish M-Score : -2.59 (As of Apr. 06, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Olympus Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.59 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Olympus's Beneish M-Score or its related term are showing as below:

TSE:7733' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.57   Max: -1.72
Current: -2.59

During the past 13 years, the highest Beneish M-Score of Olympus was -1.72. The lowest was -3.10. And the median was -2.57.


Olympus Beneish M-Score Historical Data

The historical data trend for Olympus's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Beneish M-Score Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.00 -2.78 -2.57 -2.27 -1.76

Olympus Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.72 -1.76 -2.61 -2.65 -2.59

Competitive Comparison of Olympus's Beneish M-Score

For the Medical Devices subindustry, Olympus's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Olympus's Beneish M-Score falls into.


;
;

Olympus Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Olympus for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0588+0.528 * 0.9949+0.404 * 1.2087+0.892 * 1.0787+0.115 * 1.0055
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0116+4.679 * -0.069504-0.327 * 0.9542
=-2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was 円188,762 Mil.
Revenue was 251192 + 239208 + 234821 + 260496 = 円985,717 Mil.
Gross Profit was 167979 + 166750 + 156206 + 173690 = 円664,625 Mil.
Total Current Assets was 円647,390 Mil.
Total Assets was 円1,406,931 Mil.
Property, Plant and Equipment(Net PPE) was 円260,850 Mil.
Depreciation, Depletion and Amortization(DDA) was 円66,024 Mil.
Selling, General, & Admin. Expense(SGA) was 円495,300 Mil.
Total Current Liabilities was 円414,555 Mil.
Long-Term Debt & Capital Lease Obligation was 円138,365 Mil.
Net Income was 27406 + 34395 + 14583 + 7354 = 円83,738 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = 円0 Mil.
Cash Flow from Operations was 32587 + 70455 + 23257 + 55226 = 円181,525 Mil.
Total Receivables was 円165,268 Mil.
Revenue was 239070 + 226608 + 207723 + 240378 = 円913,779 Mil.
Gross Profit was 162996 + 149661 + 137226 + 163125 = 円613,008 Mil.
Total Current Assets was 円788,140 Mil.
Total Assets was 円1,468,078 Mil.
Property, Plant and Equipment(Net PPE) was 円249,417 Mil.
Depreciation, Depletion and Amortization(DDA) was 円63,563 Mil.
Selling, General, & Admin. Expense(SGA) was 円453,886 Mil.
Total Current Liabilities was 円379,955 Mil.
Long-Term Debt & Capital Lease Obligation was 円224,718 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(188762 / 985717) / (165268 / 913779)
=0.191497 / 0.180862
=1.0588

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(613008 / 913779) / (664625 / 985717)
=0.670849 / 0.674255
=0.9949

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (647390 + 260850) / 1406931) / (1 - (788140 + 249417) / 1468078)
=0.354453 / 0.293255
=1.2087

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=985717 / 913779
=1.0787

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(63563 / (63563 + 249417)) / (66024 / (66024 + 260850))
=0.20309 / 0.201986
=1.0055

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(495300 / 985717) / (453886 / 913779)
=0.502477 / 0.496713
=1.0116

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((138365 + 414555) / 1406931) / ((224718 + 379955) / 1468078)
=0.392997 / 0.411881
=0.9542

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(83738 - 0 - 181525) / 1406931
=-0.069504

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Olympus has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.


Olympus Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Olympus's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Olympus Headlines

No Headlines